'Major moment in MS research' as new Octopus trial starts

'Major moment in MS research' as new Octopus trial starts Ailsa, now 47, is taking part in a groundbreaking new trial, which is looking into whether existing drugs can be repurposed to help slow MS progression.

The way it is designed means several drugs can be tried at the same time, and more can be added or dropped as results emerge.

The Octopus trial - so-called because it is a multi-arm, multi-stage trial - is being run by Prof Jeremy Chataway, from the National Hospital for Neurology and Neurosurgery UCLH in London, with £13m in funding from the UK's MS Society.

A similar trial design has been used to test drugs for prostate cancer and Covid. BBC News